Weight Management
Semaglutide
Physician-supervised compounded GLP-1 therapy for weight management.
Semaglutide is a GLP-1 receptor agonist studied for weight management and blood-sugar control. The Pep Club dispenses a compounded preparation of the active ingredient under U.S.-licensed physician supervision.
About this medication
Semaglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist class. The active pharmaceutical ingredient is the same molecule that appears in brand-name medications such as Ozempic and Wegovy. The Pep Club dispenses a compounded preparation of this ingredient through a licensed compounding pharmacy under U.S.-licensed physician supervision. GLP-1 mimics a natural gut hormone released after eating that plays a central role in appetite regulation and blood-sugar control. The brand-name products have been studied in the STEP clinical trial program for weight management and in the SELECT cardiovascular outcomes trial for cardiovascular risk reduction. The compounded preparation has not undergone equivalent finished-product efficacy testing; outcomes from those trials should not be assumed to transfer one-for-one to a compounded preparation. At The Pep Club, compounded semaglutide is prescribed by a licensed physician at a dose tailored to each patient. Treatment begins at a low dose and is gradually titrated upward over several weeks to minimize gastrointestinal side effects. Our physicians monitor your progress through regular telehealth consultations and adjust your protocol as appropriate.
How it works
Semaglutide is a 94% structural analog of human GLP-1 with key amino acid substitutions at positions 8 and 34 that confer resistance to DPP-4 enzymatic degradation. It binds to and activates GLP-1 receptors in the hypothalamic arcuate nucleus, stimulating POMC/CART neurons (which promote satiety) while inhibiting NPY/AgRP neurons (which drive hunger). In the gastrointestinal tract, it slows gastric emptying by reducing vagal-mediated motility, prolonging the feeling of fullness after meals. It also acts on pancreatic beta cells to enhance glucose-dependent insulin secretion and suppress glucagon release from alpha cells. The albumin-binding fatty acid side chain extends the half-life to approximately 7 days, enabling once-weekly dosing.
Clinical research context
The clinical-trial evidence for semaglutide weight management was developed for the brand-name finished product, not for any compounded preparation. The STEP trial program studied brand-name semaglutide across multiple populations (STEP 1 in adults with obesity; STEP 2 in patients with type 2 diabetes; STEP 3 with intensive behavioral therapy; STEP 4 on discontinuation; STEP 5 extended-duration data). The SELECT cardiovascular outcomes trial studied the brand-name product in overweight or obese adults without diabetes. The compounded preparation dispensed by The Pep Club has not undergone equivalent finished-product efficacy or safety testing; published brand-name trial results should be read as evidence about the molecule and its mechanism, not as a guarantee of identical outcomes from the compounded preparation. Your physician will discuss realistic expectations at consultation.
What patients describe
- GLP-1 receptor agonists have been studied for weight management
- Reduced appetite and food cravings through central-nervous-system signaling
- Improved glycemic control with lower fasting blood glucose and HbA1c (studied in the brand-name product)
- Cardiovascular risk reduction has been studied in the brand-name product (SELECT trial)
- Improvements in blood pressure and lipid profile have been studied in the brand-name product
- Designed for adherence with a consistent weekly schedule set by your physician
- Reduced visceral (abdominal) fat reported in brand-name product studies
- Potential improvements in non-alcoholic fatty-liver-disease markers (brand-name product data)
Side effects
- Nausea (most common, typically decreases over 4-8 weeks)
- Diarrhea or constipation
- Vomiting, particularly during dose escalation
- Abdominal pain or bloating
- Headache
- Fatigue
- Injection site reactions (redness, swelling)
- Decreased appetite (therapeutic effect but can be pronounced)
Contraindications
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Known hypersensitivity to semaglutide or any excipients
- History of pancreatitis
- Pregnancy or planning to become pregnant (discontinue at least 2 months before conception)
- Breastfeeding
- Severe gastroparesis or gastrointestinal disease
- End-stage renal disease (eGFR below 15 mL/min)
Drug interactions
- Insulin or sulfonylureas - increased risk of hypoglycemia; dose adjustment may be needed
- Oral contraceptives - delayed gastric emptying may reduce absorption; consider non-oral methods
- Warfarin - monitor INR more frequently during initiation and dose changes
- Levothyroxine - absorption may be affected; take thyroid medication on an empty stomach
- Oral medications with narrow therapeutic index - monitor levels due to altered absorption timing
Storage
Follow the storage instructions provided by your pharmacy and on the medication label. Do not use if the solution appears cloudy, discolored, or contains particles.
Frequently asked
How quickly will I see weight loss results with semaglutide?
Patient experience varies. Many people begin noticing reduced appetite and early weight changes within the first few weeks of physician-supervised therapy; the largest weight changes typically occur over several months in brand-name clinical trials. The compounded preparation has not undergone equivalent finished-product testing and outcomes cannot be guaranteed. Individual results vary based on starting weight, adherence, and lifestyle factors.
What happens if I stop taking semaglutide?
Brand-name trial data (STEP 4) showed that patients who discontinued semaglutide regained a portion of their lost weight over the following months, reflecting that GLP-1 therapy addresses biological drivers of weight regain that persist after weight loss. Long-term planning, including any maintenance or structured tapering strategy, is decided patient-by-patient at consultation alongside sustained lifestyle modifications. Outcomes from the compounded preparation are not guaranteed to match brand-name trial data.
How is compounded semaglutide different from brand-name Ozempic or Wegovy?
Compounded semaglutide uses the same active molecule as the brand-name finished products but is prepared by a licensed compounding pharmacy. Compounded medications are not interchangeable with the brand-name medications they may reference. All Pep Club pharmacy partners are state-licensed and follow USP 797 sterile-compounding standards including potency and sterility testing on every batch.
Can I take semaglutide if I have type 2 diabetes?
Yes, semaglutide was originally developed for type 2 diabetes management (marketed as Ozempic). However, if you are already taking diabetes medications - especially insulin or sulfonylureas - your physician will need to coordinate those medications to prevent hypoglycemia (low blood sugar). During your Pep Club consultation, disclose all current medications so your physician can create a safe, coordinated treatment plan.
Will my insurance cover compounded semaglutide?
Most insurance plans do not cover compounded medications. The Pep Club offers transparent medication pricing at $299/month for semaglutide. Physician consultations are available either pay-per-visit ($99 initial, $49 follow-up) or included with a PepWell+ membership ($49/month). This is significantly less expensive than the retail price of brand-name Wegovy ($1,300+/month) for patients without insurance coverage.
What diet and exercise changes should I make while on semaglutide?
While semaglutide can support weight management on its own, combining it with moderate lifestyle changes enhances results. A balanced, protein-rich diet helps preserve muscle during weight loss, along with regular exercise including resistance training. Your Pep Club physician can provide personalized nutrition and activity guidance during consultations. Avoid high-fat, greasy meals which can worsen nausea.
Where we can ship
Available in every state where The Pep Club has a licensed physician and a licensed pharmacy partner. Check the state availability page for the current list.
Ready to talk to a physician?
Start with our short eligibility intake. If you qualify, a licensed physician reviews your history before any prescription is issued.